Study Participants Wanted

Spotlight

Depression expert calls deep brain stimulation results promising

Rothschild compares unblinded and double-blinded studies for treatment-resistant depression

Tony Rothschild

The remarkable results of a recent clinical trial for patients with treatment-resistant depression are being met with cautious optimism by experts. UMass Medical School physician-scientist Anthony Rothschild, MD, notes that further research is needed to confirm the outcomes of the pilot study, published in Biological Psychiatry, in which six out of seven patients experienced rapid and dramatic improvement after receiving deep brain stimulation (DBS) in the medial forebrain bundle, one of several areas of the brain associated with mood disorders.  Read more...


Our Pathbreaking Work and Tradition of Service

D Ziedonis

With our clinical work, education programs and world-class research on the nature and causes of mental illness – from addiction and schizophrenia to autism spectrum disorders – the UMass Department of Psychiatry is helping individuals and families transform their lives. We are proud of our accomplishments and pleased to be a part of the nationally ranked University of Massachusetts Medical School and UMass Memorial Health Care system.

  • The department's "bench to bedside" and "bedside to community" research focuses on treatment and prevention.
  • Our training programs and approach to mentoring promote excellence in teaching for future mental health care practitioners.
  • Our products and services reach across the Commonwealth of Massachusetts and, now, are found in numerous sites internationally.
  • Our more than 300 faculty and 2,000 staff members work in many settings within the Medical School and UMass Memorial Health Care, the public sector, and the community at large.

Douglas M. Ziedonis MD, MPH
Chairman, Dept. of Psychiatry

Latest Psychiatry Department News

Lilly Award

Two UMass Psychiatry residents were presented with the Lilly award at this year’s American Psychiatric Association conference for their work with UMass’s Dr. Xiaoduo Fan on uric acid and metabolic syndrome in schizophrenia. This award, supported by an educational grant from Eli Lilly and Co., is given annually to five psychiatry residents who submit the best original, unpublished scientific paper. Shirley Rajan, MD (3rd from left) and Isheeta Zalpuri, MD (2nd from right) are pictured standing with APA President Dr. Dilip Jeste (right) and other winners at the Convocation Ceremony in San Franciso last month. (click photo to view full size)

June 19

Mark your calendars and save the date. The Public Sector Psychiatry Conference, "Mitigating the Risk of..," will be held on June 19, 2013 in the Medical School building in Worcester, Mass. Planning is underway and full details including registration information can be found on the conference web page.

Rothschild

Expert Sets Record Straight on Antidepressant Myths
Antidepressants do “really work” and do not “cause suicide,” said Anthony Rothschild, M.D., at APA’s 2013 annual meeting during a discussion of his second book in the Evidence-Based Guides series, The Evidence-based Guide to Antidepressant Medications (American Psychiatric Publishing, 2012). Read the article in the May 18 Psychiatric News Update.

Director Sheldon Benjamin

Obama Calls for Major Initiative to Advance Brain Research
Sheldon Benjamin, MD contributes to a Psychiatric News article in which the Obama administration proposes a substantial investment to map the brain’s connections and unlock secrets of cognition, memory, and learning. “Historically, researchers have looked more for the places in the brain where activity occurs, but now there is an increasing emphasis on brain networks.” Read the article.

More in the news...